CN103298795A - 用于制备来曲唑的纯中间体 - Google Patents

用于制备来曲唑的纯中间体 Download PDF

Info

Publication number
CN103298795A
CN103298795A CN2011800500261A CN201180050026A CN103298795A CN 103298795 A CN103298795 A CN 103298795A CN 2011800500261 A CN2011800500261 A CN 2011800500261A CN 201180050026 A CN201180050026 A CN 201180050026A CN 103298795 A CN103298795 A CN 103298795A
Authority
CN
China
Prior art keywords
acid
methyl
salt
iii
triazolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011800500261A
Other languages
English (en)
Chinese (zh)
Inventor
维纳亚克·戈文德·戈雷
维纳伊·库玛·舒克拉
桑迪普·梅克德
苏雷什·哈斯贝
希尔雅斯·布安达里
达南杰伊·欣德
马杜卡尔·沙利格雷姆·帕蒂尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generics UK Ltd
Original Assignee
Generics UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics UK Ltd filed Critical Generics UK Ltd
Publication of CN103298795A publication Critical patent/CN103298795A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN2011800500261A 2010-08-27 2011-08-26 用于制备来曲唑的纯中间体 Pending CN103298795A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2395MU2010 2010-08-27
IN2395/MUM/2010 2010-08-27
PCT/GB2011/051611 WO2012025762A2 (en) 2010-08-27 2011-08-26 Pure intermediate

Publications (1)

Publication Number Publication Date
CN103298795A true CN103298795A (zh) 2013-09-11

Family

ID=44653355

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011800500261A Pending CN103298795A (zh) 2010-08-27 2011-08-26 用于制备来曲唑的纯中间体

Country Status (7)

Country Link
US (1) US9150524B2 (cg-RX-API-DMAC7.html)
EP (1) EP2609087A2 (cg-RX-API-DMAC7.html)
JP (1) JP5958863B2 (cg-RX-API-DMAC7.html)
CN (1) CN103298795A (cg-RX-API-DMAC7.html)
CA (1) CA2809086A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ607428A (cg-RX-API-DMAC7.html)
WO (1) WO2012025762A2 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103664810A (zh) * 2013-12-11 2014-03-26 深圳劲创生物技术有限公司 一种合成来曲唑的工艺
CN117285477A (zh) * 2023-09-04 2023-12-26 河南康达制药有限公司 一种来曲唑的合成工艺及其装置
CN117924195A (zh) * 2023-08-23 2024-04-26 中科帆凯(大连)新材料有限公司 一种制备纯的来曲唑中间体的方法

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
WO2004076409A2 (en) * 2003-02-06 2004-09-10 Sun Pharmaceutical Industries Limited Regiospecific process for the preparation of 4-[1- (4-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
WO2005047269A1 (en) * 2003-11-14 2005-05-26 Natco Pharma Limited A method for the separation of the letrozole precursor 4-‘1-(1,2,4-triazolyl) methyl!benzonitrile from its 1,3,4-triazolyl isomer
CN1754876A (zh) * 2004-09-28 2006-04-05 北京德众万全医药科技有限公司 一种高纯度来曲唑的制备方法
WO2007039912A1 (en) * 2005-10-05 2007-04-12 Usv Limited A one pot process for the preparation of 4-[1-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
WO2007054964A2 (en) * 2005-10-20 2007-05-18 Cadila Healthcare Limited Process for the preparation of letrozole
CN101033214A (zh) * 2006-07-06 2007-09-12 上海复旦复华药业有限公司 来曲唑的制备方法
WO2007107733A1 (en) * 2006-03-17 2007-09-27 Cipla Limited Synthesis of 4-[1-(4-cyano phenyl)-(1,2,4-tr1azol-1-yl)methyl] benzonitrile and 4-[1-(1h-1,2,4-triazol-1-yl)methylene benzonitrile intermediate
WO2007144896A1 (en) * 2006-06-13 2007-12-21 Natco Pharma Limited A method of manufacture of letrozole
CN101253160A (zh) * 2005-07-06 2008-08-27 西科尔公司 制备来曲唑的改进方法
WO2009069140A1 (en) * 2007-11-28 2009-06-04 Dabur Pharma Limited An improved process for preparation of letrozole and its intermediates
WO2010146391A1 (en) * 2009-06-15 2010-12-23 Generics [Uk] Limited Regioselective synthesis of letrozole
WO2011000396A1 (en) * 2009-07-02 2011-01-06 Synthon B.V. Purification of letrozole intermediate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
AU2002366587A1 (en) 2001-12-11 2003-06-23 Emory University Bis(cyanophenyl)methyl-triazole for use in prevention of breast cancer
US20050209294A1 (en) 2004-03-17 2005-09-22 Wadhwa Lalit K Process for producing 4-(1H-1,2,4-triazol-1-ylmethyl)benzonitrile
WO2007090464A1 (en) 2006-02-08 2007-08-16 Solmag S.P.A. Process for preparing letrozole

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
WO2004076409A2 (en) * 2003-02-06 2004-09-10 Sun Pharmaceutical Industries Limited Regiospecific process for the preparation of 4-[1- (4-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
WO2005047269A1 (en) * 2003-11-14 2005-05-26 Natco Pharma Limited A method for the separation of the letrozole precursor 4-‘1-(1,2,4-triazolyl) methyl!benzonitrile from its 1,3,4-triazolyl isomer
CN1754876A (zh) * 2004-09-28 2006-04-05 北京德众万全医药科技有限公司 一种高纯度来曲唑的制备方法
CN101253160A (zh) * 2005-07-06 2008-08-27 西科尔公司 制备来曲唑的改进方法
WO2007039912A1 (en) * 2005-10-05 2007-04-12 Usv Limited A one pot process for the preparation of 4-[1-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
WO2007054964A2 (en) * 2005-10-20 2007-05-18 Cadila Healthcare Limited Process for the preparation of letrozole
WO2007107733A1 (en) * 2006-03-17 2007-09-27 Cipla Limited Synthesis of 4-[1-(4-cyano phenyl)-(1,2,4-tr1azol-1-yl)methyl] benzonitrile and 4-[1-(1h-1,2,4-triazol-1-yl)methylene benzonitrile intermediate
WO2007144896A1 (en) * 2006-06-13 2007-12-21 Natco Pharma Limited A method of manufacture of letrozole
CN101033214A (zh) * 2006-07-06 2007-09-12 上海复旦复华药业有限公司 来曲唑的制备方法
WO2009069140A1 (en) * 2007-11-28 2009-06-04 Dabur Pharma Limited An improved process for preparation of letrozole and its intermediates
WO2010146391A1 (en) * 2009-06-15 2010-12-23 Generics [Uk] Limited Regioselective synthesis of letrozole
WO2011000396A1 (en) * 2009-07-02 2011-01-06 Synthon B.V. Purification of letrozole intermediate

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103664810A (zh) * 2013-12-11 2014-03-26 深圳劲创生物技术有限公司 一种合成来曲唑的工艺
CN103664810B (zh) * 2013-12-11 2016-09-14 深圳劲创生物技术有限公司 一种合成来曲唑的工艺
CN117924195A (zh) * 2023-08-23 2024-04-26 中科帆凯(大连)新材料有限公司 一种制备纯的来曲唑中间体的方法
CN117285477A (zh) * 2023-09-04 2023-12-26 河南康达制药有限公司 一种来曲唑的合成工艺及其装置

Also Published As

Publication number Publication date
AU2011294906A8 (en) 2016-05-26
CA2809086A1 (en) 2012-03-01
AU2011294906A1 (en) 2013-03-14
US9150524B2 (en) 2015-10-06
WO2012025762A2 (en) 2012-03-01
AU2011294906B2 (en) 2016-05-19
US20130203826A1 (en) 2013-08-08
WO2012025762A3 (en) 2012-05-03
NZ607428A (en) 2015-10-30
EP2609087A2 (en) 2013-07-03
JP5958863B2 (ja) 2016-08-02
JP2013536217A (ja) 2013-09-19

Similar Documents

Publication Publication Date Title
RU2554081C2 (ru) Способ синтеза соединений диарилтиогидантоина и диарилгидантоина
JP5535082B2 (ja) ボセンタン、その多形形態及びその塩の合成方法
CN111386272A (zh) 一种改进的瑞博西尼及其盐的制备方法
WO2016135751A1 (en) Novel process for the preparation of sacubitril and its intermediates
CN111087324B (zh) 一种多拉米胺的合成方法
JP2014208718A (ja) スコピンエステルを調製するための新規プロセス
WO2016016766A2 (en) A process for the preparation of isavuconazonium or its salt thereof
JP6374436B2 (ja) 純粋なエルロチニブ
WO2011033307A1 (en) Nilotinib dihydrochloride salt
WO2019026014A1 (en) METHODS FOR PREPARING LIFITEGRAST AND ITS INTERMEDIATES
JP2019523273A (ja) ベリノスタットの多形形態、およびその調製のためのプロセス
KR101308258B1 (ko) 엔독시펜의 신규한 제조 방법
CN110612291A (zh) 2-([1,2,3]三唑-2-基)-苯甲酸衍生物的制备
US9150524B2 (en) Pure intermediate
EP1590343B1 (en) Synthesis of 2-butyl-3-(2' -(1-trityl-1h-tetrazol-5-yl)biphen yl-4-yl)-1,3-diazaspiro-4,4 -nonene-4-one
CN101939289A (zh) 用于制备伏立诺他的新方法
WO2022207788A2 (en) Process for the preparation of ribociclib and pharmaceutically acceptable salts thereof
WO2017025987A1 (en) Process for the preparation of brexpiprazole
US9499491B2 (en) One pot process for the preparation of telmisartan
WO2020053795A2 (en) Process for the preparation of acalabrutinib and its intermediates
CN106432195B (zh) 一种制备(r)-2-(2-甲基吡咯烷-2-基)-1h-苯并咪唑-4-甲酰胺的方法
WO2010146391A1 (en) Regioselective synthesis of letrozole
AU2011294906B8 (en) Pure intermediate for preparing letrozole
US20130109865A1 (en) Methods of preparing 1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone
KR101865868B1 (ko) 1-이소프로필-3-[5-[1-(3-메톡시프로필) 피페리딘-4-일]-[1,3,4]옥사디아졸-2-일]-1h-인다졸 옥살레이트의 대규모 제조공정

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130911